Le Lézard
Classified in: Business
Subject: ATY

BIOMARIN INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRN


NEW ORLEANS, Aug. 12, 2022 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues its investigation into BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN).  

On August 19, 2020, the Company disclosed that it received a Complete Response Letter ("CRL") from the FDA rejecting its Biologics License Application ("BLA") for its product, valoctocogene roxaparvovec, and recommending two years of data from the Company's ongoing 270-301 study (Phase 3) and that the Company "complete the Phase 3 Study and submit two-year follow-up safety and efficacy data on all study participants," thus requiring a lengthier study before approval would be considered.

Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws. Recently, the court presiding over the case denied the Company's motion to reconsider the court's decision denying in part the Company's motion to dismiss, allowing the case to move forward. 

KSF's investigation is focusing on whether BioMarin's officers and/or directors breached their fiduciary duties to BioMarin's shareholders or otherwise violated state or federal laws. 

If you have information that would assist KSF in its investigation, or have been a long-term holder of BioMarin shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-bmrn/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients ? including public institutional investors, hedge funds, money managers and retail investors ? in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California, Louisiana and New Jersey.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163

SOURCE Kahn Swick & Foti, LLC


These press releases may also interest you

at 16:00
Frederick Community College (FCC) and The Arc of Frederick County are partnering to offer a free event for local businesses to help promote inclusion of individuals with developmental disabilities in the workplace. The Frederick County Employment...

at 16:00
CPAmerica is continuing its partnership with Preferred Provider, Surgent by awarding a scholarship for Surgent's CPA Review Course to a CPAmerica member. This partnership began in 2019 and has since...

at 16:00
Thomas Leslie, managing shareholder of the Westchester County office of global law firm Greenberg Traurig, LLP, has been recognized on City & State's 2022 "Westchester Power 100" list. According to the publication, the list honors Westchester...

at 15:53
NexBank Capital, Inc. (the "Company"), the financial services and parent company of NexBank, today announced it closed a private placement of 20,000 shares of its Non-Cumulative Perpetual Preferred Stock, Series B, on September 23, 2022, resulting in...

at 15:42
Biofluidica, Inc., and Hamilton Company, today announced a co-marketing agreement to bring advanced Liquid Biopsy capabilities to laboratories worldwide. Biofluidica has developed the next-generation liquid biopsy platform, enabling Hamilton liquid...

at 15:35
The following issues have been halted by IIROC: Company: Clear Blue Technologies International Inc TSX-Venture Symbol: CBLU  All Issues: Yes  Reason: Pending News Halt Time (ET): 3:14 PM IIROC can make a decision to impose a temporary suspension...



News published on 12 august 2022 at 23:01 and distributed by: